2m 2m 2m 2m 2m 2m 2m
BIODESIX (BDSX)
NASDAQ
$27.40+$0.44 (+1.63%)
Price as of Sep 11, 2026 7:54 PM EDT- $284.5MMarket Cap
- 259.44%1-Year Change
- Diagnostics & ResearchIndustry
BIODESIX (BDSX)
$27.40+$0.44 (+1.63%)
BDSX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $26.96 | ||
Change | +$0.93 (+3.55%) | ||
Open | $26.12 | ||
High | $27.14 | ||
Low | $25.82 | ||
Previous Close | $26.04 | ||
Volume | 47,060 | ||
30-Day Average Volume | 119,233 | ||
1-Week Change | 3.00% | ||
1-Month Change | 10.92% | ||
1-Year Change | 259.44% | ||
3-Year Change | -4.38% | ||
5-Year Change | -86.04% | ||
Fundamentals | |||
Shares Outstanding | 10.6M | ||
Total Assets | $95.3M | ||
Market Cap | $284.5M | ||
Enterprise Value | $301.3M | ||
Period: QTR TTM FY | |||
Revenue | $26.9M | ||
Net Income | -$7.3M | ||
Free Cash Flow | -$1.8M | ||
EBIT | -$5.3M | ||
EBITDA | -$3.9M | ||
Net Working Capital | $28.3M | ||
EPS | -$0.71 | ||
Enterprise Value/EBITDA | -77 | ||
Enterprise Value/Revenue | 11 | ||
P/B | 31 | ||
P/E | -38 | ||
PEG | -3 | ||
Price/Free Cash Flow | -162 | ||
Price/Operating Cash Flow | -182 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 20 | ||
Last Split Date | 09/15/2025 | ||
Earnings & Revenue